down arrow

Remus Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0O5T01011
  • NSEID: REMUS
  • BSEID:
INR
719.95
4.2 (0.59%)
BSENSE

Dec 18

BSE+NSE Vol: 2100

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Remus Pharma.
Quarterly Analysis Highlights - QoQ
Markets Mojo
Analysis not available
Compare Quarterly Results Of Remus Pharma. With
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Remus Pharma.
Quarterly - Net Sales
Net Sales NA Cr
in

Figures in Cr
stock-summary

stock-summary

Quarterly - Consolidate Net Profit
Consolidate Net Profit NA Cr
in

Figures in Cr
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) NA Cr
in

Figures in Cr
Quarterly - Interest
Interest NA Cr
in

Figures in Cr
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) NA%
in

Figures in %
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."